Evidence map›Paper›PMID 38017352›Full record

ArticleDiabetologia2024

Disrupted hypothalamic transcriptomics and proteomics in a mouse model of type 2 diabetes exposed to recurrent hypoglycaemia.

Judit Castillo-Armengol, Flavia Marzetta, Ana Rodriguez Sanchez-Archidona, Christian Fledelius, Mark Evans, Alison McNeilly, Rory J McCrimmon, Mark Ibberson, Bernard Thorens

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Diabetologia, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Strategies for optimization of hypoglycemia rat models.Animal models and experimental medicine · 2025
    Review
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Judit Castillo-ArmengolNovo Nordisk A/S, Måløv, Denmark.ORCID 0000-0001-7833-0569
Flavia Marzetta *Vital-IT Group, SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.ORCID 0000-0002-6684-6880
Ana Rodriguez Sanchez-Archidona *Center for Integrative Genomics (CIG), University of Lausanne, Lausanne, Switzerland.ORCID 0000-0001-6002-2779
Christian FledeliusNovo Nordisk A/S, Måløv, Denmark.
Mark EvansIMS Metabolic Research Laboratories, Addenbrookes Biomedical Campus, Cambridge, UK.ORCID 0000-0001-8122-8987
Alison McNeillySchool of Medicine, University of Dundee, Dundee, UK.ORCID 0000-0003-4869-178X
Rory J McCrimmonSchool of Medicine, University of Dundee, Dundee, UK.ORCID 0000-0002-3957-1981
Mark IbbersonVital-IT Group, SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.ORCID 0000-0003-3152-5670
Bernard ThorensCenter for Integrative Genomics (CIG), University of Lausanne, Lausanne, Switzerland. Bernard.Thorens@unil.ch.ORCID 0000-0002-3738-0129
SIB Swiss Institute of Bioinformatics · CHUniversity of Dundee · GBNovo Nordisk (Denmark) · DKUniversity of Lausanne · CH

Funding

H2020 European Research Council INTEGRATE / No. 694798Innovative Medicines Initiative HypoRESOLVE / 777460Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung 310030-182496
6 · The paper itself

Abstract

aims/hypothesisRepeated exposures to insulin-induced hypoglycaemia in people with diabetes progressively impairs the counterregulatory response (CRR) that restores normoglycaemia. This defect is characterised by reduced secretion of glucagon and other counterregulatory hormones. Evidence indicates that glucose-responsive neurons located in the hypothalamus orchestrate the CRR. Here, we aimed to identify the changes in hypothalamic gene and protein expression that underlie impaired CRR in a mouse model of defective CRR.

methodsHigh-fat-diet fed and low-dose streptozocin-treated C57BL/6N mice were exposed to one (acute hypoglycaemia [AH]) or multiple (recurrent hypoglycaemia [RH]) insulin-induced hypoglycaemic episodes and plasma glucagon levels were measured. Single-nuclei RNA-seq (snRNA-seq) data were obtained from the hypothalamus and cortex of mice exposed to AH and RH. Proteomic data were obtained from hypothalamic synaptosomal fractions.

resultsThe final insulin injection resulted in similar plasma glucose levels in the RH group and AH groups, but glucagon secretion was significantly lower in the RH group (AH: 94.5±9.2 ng/l [n=33]; RH: 59.0±4.8 ng/l [n=37]; p<0.001). Analysis of snRNA-seq data revealed similar proportions of hypothalamic cell subpopulations in the AH- and RH-exposed mice. Changes in transcriptional profiles were found in all cell types analysed. In neurons from RH-exposed mice, we observed a significant decrease in expression of Avp, Pmch and Pcsk1n, and the most overexpressed gene was Kcnq1ot1, as compared with AH-exposed mice. Gene ontology analysis of differentially expressed genes (DEGs) indicated a coordinated decrease in many oxidative phosphorylation genes and reduced expression of vacuolar H CONCLUSIONS/

interpretationThe present study provides a model of defective counterregulation in a mouse model of type 2 diabetes. It shows that repeated hypoglycaemic episodes induce multiple defects affecting all hypothalamic cell types and their interactions, indicative of impaired neuronal network signalling and dysegulated hypoglycaemia sensing, and displaying features of neurodegenerative diseases. It also shows that repeated hypoglycaemia leads to specific molecular adaptation in the hypothalamus when compared with the cortex. DATA AVAILABILITY: The transcriptomic dataset is available via the GEO ( http://www.ncbi.nlm.nih.gov/geo/ ), using the accession no. GSE226277. The proteomic dataset is available via the ProteomeXchange data repository ( http://www.proteomexchange.org ), using the accession no. PXD040183.

Indexed as

Diabetes Mellitus, Type 2HypoglycemiaAmyloid beta-PeptidesAnimalsBlood GlucoseGene Expression ProfilingGlucagonHumansHypoglycemic AgentsHypothalamusInsulinMiceMice, Inbred C57BLProteomicsRNA, Small NuclearAmyloid beta-PeptidesBlood GlucoseGlucagonHypoglycemic AgentsInsulinRNA, Small NuclearAstrocytesCounterregulationGlucagonHypoglycaemiaHypothalamusInsulinNeurodegenerationNeuronsOligodendrocytesRNA-seq

Identifiers

PMID38017352
PMCPMC10789691
OpenAlexW4389076592

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.